Analysts who follow VBI Vaccines Inc (VBIV) on average expect it to gain 141.48% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns VBIV an Analyst Ranking of 79, which means it ranks higher than 79 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With VBI Vaccines Inc Stock Today?
VBI Vaccines Inc (VBIV) stock has risen 9.32% while the S&P 500 is lower by -1.01% as of 10:23 AM on Friday, Jan 15. VBIV has risen $0.30 from the previous closing price of $3.22 on volume of 13,758,958 shares. Over the past year the S&P 500 has gained 13.28% while VBIV has risen 97.75%. VBIV lost -$0.21 per share the over the last 12 months.
Click Here to get the full report on VBI Vaccines Inc (VBIV) Stock.